scholarly article | Q13442814 |
P50 | author | Marc Lipsitch | Q28322531 |
Stephen I Pelton | Q41485813 | ||
Susan S. Huang | Q62772766 | ||
Ken P Kleinman | Q73208566 | ||
William P. Hanage | Q89637656 | ||
Sheryl L Rifas-Shiman | Q90866339 | ||
Jonathan A Finkelstein | Q97578568 | ||
Grace M Lee | Q105289067 | ||
P2093 | author name string | Virginia L Hinrichsen | |
Abbie E Stevenson | |||
P2860 | cites work | Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine | Q22250891 |
Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine | Q28306783 | ||
Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage | Q30229942 | ||
Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample | Q33193596 | ||
Vaccine escape recombinants emerge after pneumococcal vaccination in the United States | Q33306103 | ||
Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts | Q33312892 | ||
Efficacy of a pneumococcal conjugate vaccine against acute otitis media | Q33932973 | ||
Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study | Q35967600 | ||
Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience | Q36497899 | ||
Pneumococcal necrotizing pneumonia in Utah: does serotype matter? | Q36905065 | ||
Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine | Q37344869 | ||
Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates | Q39700578 | ||
Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005. | Q40124157 | ||
Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. | Q40166390 | ||
The influence of mutation, recombination, population history, and selection on patterns of genetic diversity in Neisseria meningitidis | Q43520723 | ||
Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. | Q43572587 | ||
Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine | Q43633818 | ||
Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children | Q44259087 | ||
Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States | Q45008464 | ||
Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente | Q46341871 | ||
Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine | Q46849891 | ||
Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children | Q46947680 | ||
Reduction of antibiotic use in the community reduces the rate of colonization with penicillin G-nonsusceptible Streptococcus pneumoniae | Q47733684 | ||
Trends in antimicrobial prescribing rates for children and adolescents. | Q50696986 | ||
Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. | Q51102158 | ||
Antibiotic prescribing by primary care physicians for children with upper respiratory tract infections. | Q51698378 | ||
Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. | Q53855445 | ||
Diversity and Antibiotic Resistance among Nonvaccine Serotypes ofStreptococcus pneumoniaeCarriage Isolates in the Post–Heptavalent Conjugate Vaccine Era | Q56762382 | ||
Editorial Commentary:Replacement Pneumococcal Disease in Perspective | Q59692239 | ||
Emergence of Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes in the Era of 7-Valent Conjugate Vaccine | Q61322861 | ||
Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization | Q64131295 | ||
Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine | Q71825810 | ||
Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers | Q73509127 | ||
Will reduction of antibiotic use reduce antibiotic resistance?: The pneumococcus paradigm | Q79150682 | ||
Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era | Q80121211 | ||
Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life | Q80838507 | ||
Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003 | Q81216904 | ||
Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine | Q81402633 | ||
Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniae--Massachusetts, 2001-2006 | Q81464895 | ||
Does it really take longer not to prescribe antibiotics for viral respiratory tract infections in children? | Q83817430 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pneumococcal conjugate vaccine | Q7205991 |
vaccine | Q134808 | ||
P304 | page(s) | e1-11 | |
P577 | publication date | 2009-07-01 | |
P1433 | published in | Pediatrics | Q7159238 |
P1476 | title | Continued impact of pneumococcal conjugate vaccine on carriage in young children | |
P478 | volume | 124 |